Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark Neumann. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Mark Neumann has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ITCI / Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark Neumann. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Mark Neumann as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-04-02 2025-04-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
D - Sale to Issuer -52,811 0 -100.00 132.00 -6,971,052
2025-03-10 2025-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -3,116 52,811 -5.57 131.24 -408,944 6,930,916
2025-03-10 2025-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7,345 55,927 15.12
2025-03-10 2025-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -5,572 48,582 -10.29 131.19 -730,991 6,373,473
2025-03-10 2025-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13,133 54,154 32.02
2025-03-04 2025-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -3,709 41,021 -8.29 128.20 -475,494 5,258,892
2025-03-04 2025-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 8,742 44,730 24.29
2025-02-04 2025-01-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -4,729 35,988 -11.61 127.00 -600,583 4,570,476
2025-02-04 2025-01-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 11,017 40,717 37.09
2024-08-20 2024-08-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -18,714 29,700 -38.65 75.08 -1,405,047 2,229,876
2024-08-20 2024-08-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 18,714 48,414 63.01 36.89 690,359 1,785,992
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1,313 29,700 -4.23 66.86 -87,787 1,985,742
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1,729 31,013 -5.28 65.92 -113,976 2,044,377
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,303 32,742 -11.62 65.11 -280,168 2,131,832
2024-03-11 2024-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7,345 37,045 24.73
2024-03-11 2024-03-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,496 29,700 -13.15 66.95 -301,007 1,988,415
2024-03-11 2024-03-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -8,636 34,196 -20.16 66.37 -573,171 2,269,589
2024-03-08 2024-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13,132 42,832 44.22
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1,307 29,700 -4.22 71.18 -93,032 2,114,046
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -2,341 31,007 -7.02 70.70 -165,509 2,192,195
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,059 33,348 -10.85 69.56 -282,344 2,319,687
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -200 37,407 -0.53 68.03 -13,606 2,544,798
2024-02-27 2024-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7,907 37,607 26.62
2024-02-05 2024-02-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6,904 29,700 -18.86 67.49 -465,951 2,004,453
2024-02-05 2024-02-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,956 36,604 -11.92 66.67 -330,417 2,440,389
2024-02-05 2024-02-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 11,860 41,560 39.93
2023-11-08 2023-11-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -15,639 29,700 -34.49 55.02 -860,417 1,634,017
2023-11-08 2023-11-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -26,754 45,339 -37.11 55.98 -1,497,734 2,538,154
2023-11-08 2023-11-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 26,754 72,093 59.01 23.94 640,491 1,725,906
2023-08-09 2023-08-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -55,300 45,339 -54.95 58.79 -3,251,087 2,665,480
2023-08-09 2023-08-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 55,300 100,639 121.97 18.59 1,028,027 1,870,879
2023-03-30 2023-03-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -10,183 45,339 -18.34 54.01 -549,984 2,448,759
2023-03-30 2023-03-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -5,421 55,522 -8.90 54.86 -297,396 3,045,937
2023-03-13 2023-03-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -423 60,943 -0.69 44.05 -18,633 2,684,539
2023-03-13 2023-03-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -3,335 61,366 -5.15 45.10 -150,408 2,767,607
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7,344 64,701 12.80
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1,800 57,357 -3.04 42.74 -76,932 2,451,438
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6,750 59,157 -10.24 43.50 -293,625 2,573,330
2023-03-13 2023-03-09 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 16,708 65,907 33.96
2023-03-03 2023-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -7,241 49,199 -12.83 50.01 -362,122 2,460,442
2023-02-27 2023-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,046 56,440 -6.69 47.12 -190,648 2,659,453
2023-02-27 2023-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7,906 60,486 15.04
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -635 52,580 -1.19 48.93 -31,071 2,572,739
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -123 53,215 -0.23 47.32 -5,820 2,518,134
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -3,140 53,338 -5.56 46.61 -146,355 2,486,084
2023-02-22 2023-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11,139 56,478 24.57
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
M - Exercise -86,348 0 -100.00
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -14,885 45,339 -24.72 65.14 -969,609 2,953,382
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -53,987 60,224 -47.27 64.42 -3,477,843 3,879,630
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -17,476 114,211 -13.27 63.55 -1,110,600 7,258,109
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 86,348 131,687 190.45 12.73 1,099,210 1,676,376
2022-03-14 2022-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 22,034 22,034
2022-03-14 2022-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 17,916 17,916
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1,371 45,339 -2.94 51.33 -70,373 2,327,251
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -3,875 46,710 -7.66 52.03 -201,616 2,430,321
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -2,660 50,585 -5.00 52.94 -140,820 2,677,970
2022-02-25 2022-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -7,906 15,813 -33.33
2022-02-25 2022-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7,906 53,245 17.44
2022-02-23 2022-02-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,607 45,339 -9.22 54.84 -252,648 2,486,391
2022-02-23 2022-02-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6,532 49,946 -11.57 55.60 -363,179 2,776,998
2022-02-23 2022-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -11,139 11,139 -50.00
2022-02-23 2022-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11,139 56,478 24.57
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,252 45,339 -8.57 40.09 -170,463 1,817,641
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -13,935 49,591 -21.94 40.80 -568,548 2,023,313
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -2,761 63,526 -4.17 41.74 -115,244 2,651,575
2022-01-11 2022-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -20,948 0 -100.00
2022-01-11 2022-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20,948 66,287 46.20
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -500 45,339 -1.09 38.88 -19,440 1,762,780
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1,958 45,839 -4.10 39.44 -77,224 1,807,890
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,288 47,797 -8.23 40.77 -174,822 1,948,684
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6,702 52,085 -11.40 41.49 -278,066 2,161,007
2021-10-19 2021-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -13,448 0 -100.00
2021-10-19 2021-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13,448 58,787 29.66
2021-02-25 2021-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 23,719 23,719
2021-02-25 2021-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 18,714 18,714
2021-02-22 2021-02-19 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -600 45,339 -1.31 38.90 -23,340 1,763,687
2021-02-22 2021-02-19 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4,584 45,939 -9.07 39.26 -179,968 1,803,565
2021-02-22 2021-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -11,139 22,278 -33.33
2021-02-22 2021-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11,139 50,523 28.28
2021-01-12 2021-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -9,684 39,384 -19.74 32.02 -310,082 1,261,076
2021-01-12 2021-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -20,948 20,948 -50.00
2021-01-12 2021-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20,948 49,068 74.50
2020-10-16 2020-10-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6,792 28,120 -19.45 26.80 -182,026 753,616
2020-10-16 2020-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -13,448 13,448 -50.00
2020-10-16 2020-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13,448 34,912 62.65
2020-02-20 2020-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 33,417 33,417
2020-02-20 2020-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 26,754 26,754
2020-01-10 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -20,947 41,896 -33.33
2020-01-10 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
J - Other -6,157 21,464 -22.29 26.34 -162,175 565,362
2020-01-10 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20,947 27,621 313.86
2019-10-17 2019-10-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6,774 6,674 -50.37 8.25 -55,886 55,060
2019-10-17 2019-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -13,448 26,896 -33.33
2019-10-17 2019-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Common stock
M - Exercise 13,448 13,448
2019-01-10 2019-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 62,843 62,843
2019-01-10 2019-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 86,348 86,348
2018-10-17 2018-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 40,344 40,344
2018-10-17 2018-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 55,300 55,300
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)